The authors of this Review discuss current indications for treatment in patients with autoimmune hepatitis, conventional management regimens, therapeutic end points and treatment outcomes. Factors that influence the treatment response, empiric salvage therapies, and promising pharmacological and molecular interventions are also considered.
- Aldo J Montano Loza
- Albert J Czaja